The Pediatric Neurotransmitter Disorders

@article{Pearl2007ThePN,
  title={The Pediatric Neurotransmitter Disorders},
  author={Phillip L. Pearl and Jacob L Taylor and Stacey Trzcinski and Alex Sokohl},
  journal={Journal of Child Neurology},
  year={2007},
  volume={22},
  pages={606 - 616}
}
The pediatric neurotransmitter disorders represent an enlarging group of neurological syndromes characterized by abnormalities of neurotransmitter synthesis and breakdown. The disorders of dopamine and serotonin synthesis are aromatic amino acid decarboxylase deficiency, tyrosine hydroxylase deficiency, and disorders of tetrahydrobiopterin synthesis. Amino acid decarboxylase, tyrosine hydroxylase, sepiapterin reductase, and guanosine triphosphate cyclohydrolase (Segawa disease) deficiencies do… 

Figures and Tables from this paper

Monoamine neurotransmitter deficiencies.
  • P. Pearl
  • Biology, Psychology
    Handbook of clinical neurology
  • 2013
Disorders of monoamine metabolism: inherited disorders frequently misdiagnosed as epilepsy
TLDR
The pathogenesis and diagnosis of these neurotransmitter disorders are discussed, with the hope that correct diagnosis of pediatric neurotransmitter diseases can reduce the unnecessary AED treatment.
Clinical Use of CSF Neurotransmitters.
The phenotypic spectrum of paediatric neurotransmitter diseases and infantile parkinsonism
  • R. Pons
  • Medicine, Biology
    Journal of Inherited Metabolic Disease
  • 2008
TLDR
Paediatric neurotransmitter diseases are a group of inherited disorders attributable to a disturbance of neurotransmitter metabolism that comprise a wide spectrum of manifestations, with motor dysfunction being the most prominent clinical feature.
Inherited Neurotransmitter Disorders
TLDR
CSF neurotransmitter measurements would be necessary to diagnose inherited neurotransmitter disorders for the initiation of the disease-specific treatment.
Approaches for diagnosis and treatment in neurotransmitter disorders of childhood.
TLDR
Investigation of neurotransmitters in CSF and analysis of related genes are essential to differentiate disturbances of monoamine neurotransmitter metabolism from other neurometabolic diseases.
Novel mutations in the tyrosine hydroxylase gene in the first Czech patient with tyrosine hydroxylase deficiency.
TLDR
Analysis of neurotransmitter metabolites in CSF revealed two novel heterozygous mutations c.636A and c.1124G in the TH gene, which resulted in the treatment with L-DOPA/carbidopa resulting in the improvement of dystonia.
The neurochemical consequences of aromatic L-amino acid decarboxylase deficiency
TLDR
The results indicate the need for investigations addressing the effects of chronic 5-HTP exposure as only acute effects were investigated in the current study, and suggest maintaining adequate PLP availability may be important for optimal treatment of AADC deficiency.
A new perspective on the treatment of aromatic L-amino acid decarboxylase deficiency.
Prevalence of inherited neurotransmitter disorders in patients with movement disorders and epilepsy: a retrospective cohort study
TLDR
Prevalence of inherited neurotransmitter disorders was 4% in a retrospective cohort study and eight out of the 150 patients had one of the treatable inherited metabolic disorders with favorable short-term neurodevelopmental outcomes, highlighting the importance of an early and specific diagnosis.
...
...

References

SHOWING 1-10 OF 74 REFERENCES
Inherited disorders of neurotransmitters in children and adults.
Clinical aspects of the disorders of GABA metabolism in children
Purpose of reviewThere has been increased recognition of the pediatric neurotransmitter disorders. This review focuses on the clinical disorders of GABA metabolism. Recent findingsThe known clinical
Neurodevelopmental pattern of succinic semialdehyde dehydrogenase deficiency (gamma-hydroxybutyric aciduria).
TLDR
Features of SSADH deficiency are: early impaired psychomotor development with hypotonia and disturbances in motor coordination; impaired development of language, mainly due to poor auditory perception; and seizures and psychotic features in late adolescence or adulthood.
Aromatic L‐amino acid decarboxylase deficiency
We report the clinical features, biochemical details, and treatment of the first detected cases of an inborn error of aromatic L-amino acid decarboxylase. Male monozygotic twins presented with
Aromatic L-amino acid decarboxylase deficiency with hyperdopaminuria. Clinical and laboratory findings in response to different therapies.
TLDR
The clinical, biochemical and molecular details of two affected brothers, one of whom, despite the lack of AADC, presented with hyperdopaminuria, are described and his reactions to treatment with dopaminergic agonists, monoamine oxidase inhibitors and pyridoxine are detailed.
Aromatic L‐amino acid decarboxylase deficiency: Overview of clinical features and outcomes
In this paper, we provide a brief update of diagnostic considerations and biochemical phenotype in L‐amino acid decarboxylase deficiency. We review clinical features and outcome data in 11 affected
Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease)
TLDR
Partial deficiency of tetrahydrobiopterin caused by heterozygous mutation of the GCH‐I gene decreases dopamine activity rather selectively which affects the DA receptors that mature early and demonstrates characteristic symptoms age‐dependently along with the developmental decrement of the tyrosine hydroxylase activities at the terminals and the maturational processes of the projecting neurons of the basal ganglia.
Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia.
TLDR
It is proposed that, for the biosynthesis of BH(4) in peripheral tissues, SR activity may be substituted by aldose reductase (AR), carbonyl reductases (CR), and dihydrofolate reduct enzyme, whereas, in the brain, only AR and CR are fully present.
Clinical spectrum of succinic semialdehyde dehydrogenase deficiency
TLDR
Urine organic acid analysis should include a sensitive method for the detection of 4-hydroxybutyrate and should be obtained from patients with mental retardation or neuropsychiatric disturbance of unknown etiology, the authors say.
...
...